Found: 23
Select item for more details and to access through your institution.
Cardiac effects of muscarinic receptor antagonists used for voiding dysfunction.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 186, doi. 10.1111/j.1365-2125.2010.03813.x
- By:
- Publication type:
- Article
Pilot of a National Inpatient Medication Chart in Australia: improving prescribing safety and enabling prescribing training.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 338, doi. 10.1111/j.1365-2125.2011.03967.x
- By:
- Publication type:
- Article
Effects of the moderate CYP3A4 inhibitor, fluconazole, on the pharmacokinetics of fesoterodine in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 263, doi. 10.1111/j.1365-2125.2011.04007.x
- By:
- Publication type:
- Article
Population pharmacokinetic analysis of sorafenib in patients with solid tumours.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 294, doi. 10.1111/j.1365-2125.2011.03963.x
- By:
- Publication type:
- Article
SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 282, doi. 10.1111/j.1365-2125.2011.03968.x
- By:
- Publication type:
- Article
Systemic bioavailability of hydrofluoroalkane formulations containing fluticasone and salmeterol: a reply.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 355, doi. 10.1111/j.1365-2125.2011.03979.x
- By:
- Publication type:
- Article
Important details to be clarified about the effect of rectal ozone on the portal vein oxygenation.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 350, doi. 10.1111/j.1365-2125.2011.03974.x
- By:
- Publication type:
- Article
Systemic bioavailability of hydrofluoroalkane formulations containing fluticasone propionate and salmeterol.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 353, doi. 10.1111/j.1365-2125.2011.03978.x
- By:
- Publication type:
- Article
Clinical pharmacology of functional disorders of the urogenital system.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Effects of fesoterodine on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 257, doi. 10.1111/j.1365-2125.2011.03989.x
- By:
- Publication type:
- Article
Phosphodiesterase (PDE) inhibitors in the treatment of lower urinary tract dysfunction.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 197, doi. 10.1111/j.1365-2125.2010.03828.x
- By:
- Publication type:
- Article
α<sub>1</sub>-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 205, doi. 10.1111/j.1365-2125.2011.03922.x
- By:
- Publication type:
- Article
Translation Section.
- Published in:
- 2011
- Publication type:
- Other
Omalizumab decreases IgE production in patients with allergic (IgE-mediated) asthma; PKPD analysis of a biomarker, total IgE.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 306, doi. 10.1111/j.1365-2125.2011.03962.x
- By:
- Publication type:
- Article
Tamsulosin shows a higher unbound drug fraction in human prostate than in plasma: a basis for uroselectivity?
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 218, doi. 10.1111/j.1365-2125.2010.03870.x
- By:
- Publication type:
- Article
Important details to be clarified about the effect of rectal ozone on the portal vein oxygenation.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 352, doi. 10.1111/j.1365-2125.2011.03973.x
- By:
- Publication type:
- Article
Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997-2007.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 330, doi. 10.1111/j.1365-2125.2011.03908.x
- By:
- Publication type:
- Article
Comparison of pharmacokinetic variability of fesoterodine vs. tolterodine extended release in cytochrome P450 2D6 extensive and poor metabolizers.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 226, doi. 10.1111/j.1365-2125.2011.03948.x
- By:
- Publication type:
- Article
Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosin.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 247, doi. 10.1111/j.1365-2125.2011.03988.x
- By:
- Publication type:
- Article
Erratum.
- Published in:
- 2011
- Publication type:
- Erratum
A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 235, doi. 10.1111/j.1365-2125.2011.03961.x
- By:
- Publication type:
- Article
Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 321, doi. 10.1111/j.1365-2125.2011.03972.x
- By:
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 2, p. 270, doi. 10.1111/j.1365-2125.2011.03964.x
- By:
- Publication type:
- Article